g. they included age , sex , weight , amb dose , duration and indication , duration of amb infusion , type of co administered medications that may exacerbate or attenuate amb nephrotoxicity , length of hospital stay , and mortality. 4. using the stepwise method ,. a flowchart detailing the reasons patients dropped out of the study is presented in figure 1. no patient received cisplatin , ifosfamide , cyclophosphamide , dopamine , and mannitol during the study period. 36 days.